Trastuzumab, commonly known by the brand name Herceptin, is a monoclonal antibody used primarily in the treatment of certain types of breast cancer. It specifically targets the HER2 receptor, a protein that promotes the growth of cancer cells. Trastuzumab binds to these receptors and inhibits their action, thereby slowing down or stopping the growth of the cancer.
